EUVIMEDEUVIMED entdecken
Fallbericht

NF1 Mutated Gastrointestinal Stromal Tumors With Coamplification of MDM2 and MYC

Xinyang Chen, Yang Lu, Xin He iD, Du He, Min Chen, Hongying Zhang

Genes, Chromosomes and Cancer · 2025

DOI: 10.1002/gcc.70096 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Genes, Chromosomes and Cancer, 2025. Verfasst von Xinyang Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Gastrointestinal Stromal Tumors, Proto-Oncogene Proteins c-mdm2, Neurofibromin 1, Proto-Oncogene Proteins c-myc. Die Arbeit nennt 23 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Sichuan Science and Technology Program, Cadre Health Research Project of Sichuan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We report a unique case of a 57‐year‐old man with a gastrointestinal stromal tumor (GIST) that developed a high‐grade phenotype and additional genetic alterations in the subsequent recurrence. Histologically, the initial resected tumor showed a typical morphology with uniform spindle‐shaped cells arranged in fascicular and whorling patterns. However, based on large tumor size and mitotic activity it was designated as high risk. Tumor cells were immunoreactive for CD117 and DOG1. Mutational analysis identified no KIT or PDGFRA hotspot mutations. Next‐generation sequencing (NGS) further demonstrated an NF1 mutation (c.1466A>G) without KIT or PDGFRA mutations. In contrast, the recurrent tumor displayed a higher‐grade morphology. Tumor cells were positive for MDM2, while showing decreased expression for CD117 and DOG1. NGS and molecular assays detected no KIT or PDGFRA mutations, but confirmed the NF1 mutation (c.1466A>G). In addition, NGS identified MDM2 and MYC amplification. This is the first report describing an NF1 ‐mutant GIST harboring coamplification of MDM2 and MYC and associated with a higher‐grade tumor progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal Stromal TumorsProto-Oncogene Proteins c-mdm2Neurofibromin 1Proto-Oncogene Proteins c-mycGastrointestinal NeoplasmsHumansMaleMiddle AgedMutationAnoctamin-1Neoplasm Proteins

Stichwörter der Autor:innen

MDM2 amplificationMYC amplificationNF1 mutationgastrointestinal stromal tumorshigher‐grade transformationtumor progression

Substanzen

Proto-Oncogene Proteins c-mdm2MDM2 protein, humanNeurofibromin 1NF1 protein, humanProto-Oncogene Proteins c-mycMYC protein, humanANO1 protein, humanAnoctamin-1Neoplasm Proteins

Autor:innen und Institutionen

  • Department of Pathology, West China Hospital, Sichuan University, Chengdu, China.

ORCID-Profile: Xin He

Förderung

  • National Natural Science Foundation of China
  • Sichuan Science and Technology Program
  • Cadre Health Research Project of Sichuan Province
  • 1·3·5 projects for Artificial Intelligence

Zitieren

APA

Chen, X., Lu, Y., He, X., He, D., Chen, M., & Zhang, H. (2025). NF1 Mutated Gastrointestinal Stromal Tumors With Coamplification of MDM2 and MYC. Genes, Chromosomes and Cancer. https://doi.org/10.1002/gcc.70096

Vancouver

Chen X, Lu Y, He X, He D, Chen M, Zhang H. NF1 Mutated Gastrointestinal Stromal Tumors With Coamplification of MDM2 and MYC. Genes, Chromosomes and Cancer. 2025. doi:10.1002/gcc.70096

BibTeX
@article{Chen2025,
  author = {Chen, Xinyang and Lu, Yang and He, Xin and He, Du and Chen, Min and Zhang, Hongying},
  title = {NF1 Mutated Gastrointestinal Stromal Tumors With Coamplification of MDM2 and MYC},
  journal = {Genes, Chromosomes and Cancer},
  year = {2025},
  doi = {10.1002/gcc.70096}
}
Kostenlos starten →